Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

What Is the Cheapest "Magnificent Seven" Stock?: https://g.foolcdn.com/editorial/images/869968/three-people-debating-on-stock-data-information.jpg
What Is the Cheapest "Magnificent Seven" Stock?

The "Magnificent Seven" group of stocks includes some of the largest companies in the world, all of which are major players in the tech realm. This group is made up of:

All seven of these stocks are

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping RallyPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally

Boxer Capital Management increased its stake in Kodiak Sciences (NASDAQ:KOD) during the first quarter, adding 225,000 shares in a transaction estimated at $5.81 million based on quarterly average

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million SharesPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares

On May 15, 2026, Boxer Capital Management disclosed a purchase of 1,241,000 Vir Biotechnology (NASDAQ:VIR) shares, an estimated $9.89 million trade based on quarterly average pricing.

According to a

A China Tech Fund Opens a Biotech Position — Here's What That Actually SignalsPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
A China Tech Fund Opens a Biotech Position — Here's What That Actually Signals

First Beijing Investment Ltd disclosed a new position in Legend Biotech (NASDAQ:LEGN), acquiring 2,296,335 shares in the first quarter, with the estimated trade valued at $43.78 million based on

Nvidia Stock Is Poised to Rocket From the Booming Space Economy: https://g.foolcdn.com/editorial/images/870661/nvda-stock-space-stocks-space-economy.jpg
Nvidia Stock Is Poised to Rocket From the Booming Space Economy

Nvidia dominates artificial intelligence (AI) chips and infrastructure on Earth – and it's poised to do the same for space applications, both from in-space and Earth, in my view.

As such, if you're

With YMM Down 29%, First Beijing Bought 13 Million More Shares
With YMM Down 29%, First Beijing Bought 13 Million More Shares

First Beijing Investment Ltd disclosed in a May 13, 2026, SEC filing that it bought 13,384,327 shares of Full Truck Alliance (NYSE:YMM), an estimated $127.30 million trade based on quarterly average

GDS Was Already Up 47% — Pinpoint Tripled Its Stake Anyway
GDS Was Already Up 47% — Pinpoint Tripled Its Stake Anyway

On May 13, 2026, Pinpoint Asset Management (Singapore) Pte. Ltd. disclosed buying 247,034 shares of GDS Holdings Limited (NASDAQ:GDS), an estimated $10.59 million trade based on quarterly average

The AI Stock With a 10-Year Head Start That Wall Street Still Hasn't Fully Priced In: https://g.foolcdn.com/editorial/images/868261/googl.png
The AI Stock With a 10-Year Head Start That Wall Street Still Hasn't Fully Priced In

As the expenses of building and running artificial intelligence (AI) data centers continue to surge, having lower costs is a huge advantage. One of the best ways to achieve this is with custom chips

Why Plug Power Stock Skyrocketed This Week: https://g.foolcdn.com/editorial/images/870652/finance-66.jpg
Why Plug Power Stock Skyrocketed This Week

Plug Power (NASDAQ: PLUG) stock rallied in this week's trading, rising 21.1% across the stretch. Meanwhile, the S&P 500 was up 0.1%, and the Nasdaq Composite was down 0.1%.

Plug Power published its

Think Delaying Social Security Is Risky? The Truth About Timing Your Benefits.: https://g.foolcdn.com/editorial/images/869863/older-man-playing-chess-strategy-moves-winning.jpg
Think Delaying Social Security Is Risky? The Truth About Timing Your Benefits.

You want to sign up for Social Security at the right time so you get the most money possible, but it's not always easy to figure out when that is. Many people caution against waiting too long to

Snapchat: Don't Rush to Buy This Social Media Stock: https://g.foolcdn.com/editorial/images/869916/gettyimages-1413735503-1201x710-7a55fa6.jpg
Snapchat: Don't Rush to Buy This Social Media Stock

It's been a tough ride for long-term Snap (NYSE: SNAP) investors. Once touted as a close rival to Meta Platforms' Instagram, the relatively small social media company remains unprofitable and is

M&G Shaved 2.4% of Methanex After a Near-DoublingPhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
M&G Shaved 2.4% of Methanex After a Near-Doubling

On May 13, 2026, M&G PLC disclosed it sold 303,555 shares of Methanex (NASDAQ:MEOH) in the first quarter, an estimated $15.27 million trade based on quarterly average pricing.

According to an SEC

Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares

On May 15, 2026, HighVista Strategies disclosed it sold 70,503 shares of Maze Therapeutics (NASDAQ:MAZE) in Q1 2026, an estimated $3.11 million trade based on quarterly average pricing.

According to

Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares

On May 15, 2026, HighVista Strategies disclosed a purchase of 96,218 shares of Tyra Biosciences (NASDAQ:TYRA), estimated at $3.11 million based on quarterly average pricing.

According to its SEC

This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 MillionPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million

HighVista Strategies reported a sale of 238,243 shares of Viridian Therapeutics (NASDAQ:VRDN) in its May 15, 2026, SEC filing, an estimated $7.08 million trade based on quarterly average pricing.

Where Could Palantir Be in 10 Years? The Bull and Bear Cases.: https://g.foolcdn.com/editorial/images/869883/gettyimages-157417912.jpg
Where Could Palantir Be in 10 Years? The Bull and Bear Cases.

Few large-cap stocks polarize investors the way Palantir Technologies (NASDAQ: PLTR) does right now. The company has gone from being labeled a software consultancy to being considered a provider of

Why Poet Technologies Stock Skyrocketed This Week: https://g.foolcdn.com/editorial/images/870655/gettyimages-1260182535-copy.jpg
Why Poet Technologies Stock Skyrocketed This Week

Poet Technologies (NASDAQ: POET) stock recorded massive gains over the last week of trading. The photonics company's share price surged 45.8% higher over the stretch.

Poet stock roared higher this

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million

HighVista Strategies sold 69,092 shares of Structure Therapeutics (NASDAQ:GPCR) in the first quarter, an estimated $4.73 million trade based on quarterly average pricing, per the May 15, 2026 SEC

Ares Capital's 10% Yield Just Survived a Tough Quarter. Is the BDC Still a Buy?: https://g.foolcdn.com/editorial/images/870036/a-person-measuring-a-yield-sign.jpg
Ares Capital's 10% Yield Just Survived a Tough Quarter. Is the BDC Still a Buy?

Ares Capital's (NASDAQ: ARCC) main draw is its monster dividend yield. At more than 10%, it's nearly 10 times higher than the S&P 500's yield.

The business development company (BDC) has paid a

Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter

On May 15, 2026, Cormorant Asset Management disclosed a buy of 313,645 shares of Alumis (NASDAQ:ALMS), with the estimated transaction value at $7.84 million based on quarterly average pricing.

Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally

On May 15, 2026, Cormorant Asset Management disclosed a new position in Dianthus Therapeutics (NASDAQ:DNTH), acquiring 950,000 shares in an estimated $55.01 million trade based on quarterly average

Why Would Anyone Buy SPYM Instead of QQQ?: https://g.foolcdn.com/editorial/images/868664/getty-safe-secure-umbrella-retirement-1200x800-5b2df79.jpg
Why Would Anyone Buy SPYM Instead of QQQ?

If you've been following the stock market for the past few years, you might assume that tech stocks are always the best place to put your money. Tech stocks always outperform the S&P 500 index

Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million MorePhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More

Cormorant Asset Management disclosed a new position in Erasca (NASDAQ:ERAS) in its May 15, 2026, SEC filing, purchasing 5,800,000 shares in a trade estimated at $68.55 million based on quarterly

Micron's and Sandisk's Futures Are Heavily Influenced by 2 Foreign Chip Companies. Here's How to Buy Them.: https://g.foolcdn.com/editorial/images/870122/gettyimages-handling-silicon-wafer.jpg
Micron's and Sandisk's Futures Are Heavily Influenced by 2 Foreign Chip Companies. Here's How to Buy Them.

Demand for memory chips has skyrocketed over the past year as big tech companies upped their spending on artificial intelligence (AI) data centers. That's been a huge boon for both Micron Technology

AI Supercharged This Flatlining U.S. Manufacturing Stock. Now It's Just Scored a Massive New Nvidia Partnership.: https://g.foolcdn.com/editorial/images/869701/gettyimages-2045262949-1201x633-65d4be6-1.jpg
AI Supercharged This Flatlining U.S. Manufacturing Stock. Now It's Just Scored a Massive New Nvidia Partnership.

Since the artificial intelligence (AI) revolution began in late 2022, chipmaker Nvidia (NASDAQ: NVDA) has seen its shares soar more than 700% as it dominated the market for high-end AI processors.